Reference health
Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
23/23 checkable references clean · checked 2026-07-24
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 23 checked references that resolve
resolves10.1002/pds.v25.9
resolves10.1186/s12879-016-2091-0
Regional variation in antibiotic prescribing among medicare part D enrollees, 2013
resolves10.1016/j.jacc.2021.02.047
Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm
resolves10.1001/jamainternmed.2016.5651
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
resolves10.1177/1060028019865224
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections
resolves10.1002/pds.v29.6
resolves10.1017/ice.2019.247
Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals
resolves10.1001/jamainternmed.2021.1154
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends
resolves10.1111/1475-6773.13630
Physician variation in the de‐adoption of ineffective statin and fibrate therapy
resolves10.1007/s10754-020-09282-2
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm
resolves10.1186/s12916-015-0488-z
Towards understanding the de-adoption of low-value clinical practices: a scoping review
resolves10.1001/jamainternmed.2015.0157
Effect of Published Scientific Evidence on Glycemic Control in Adult Intensive Care Units
resolves10.1136/bmjopen-2018-024159
Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study
resolves10.1097/MLR.0000000000000735
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data
resolves10.1016/j.acap.2013.08.002
Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
resolves10.1046/j.1365-2710.2002.00430.x
Segmented regression analysis of interrupted time series studies in medication use research
resolves10.1007/s41669-016-0007-y
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015
resolves10.3390/antibiotics8020084
Qualitative Analysis of Primary Care Provider Prescribing Decisions for Urinary Tract Infections
resolves10.1016/j.jcrc.2015.12.007
Adoption and de-adoption of drotrecogin alfa for severe sepsis in the United States
resolves10.1128/AAC.02897-15
Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012
resolves10.1155/2012/976273
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
The 7 references without a DOI — listed, not checked
no DOI — not checkedUptake and utilization of practice guidelines in hospitals in the United States: the case of routine episiotomy.
no DOI — not checkedUS outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011.
no DOI — not checkedUS Food and Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients: FDA Drug Safety Communication. December 21, 2018. Accessed April 10, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics
no DOI — not checkedUS Food and Drug Administration. FDA Drug Safety Communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection. August 15, 2013. Accessed April 10, 2020. http://wayback.archive-it.org/7993/20170112031629/http://www.fda.gov/Drugs/DrugSafety/ucm365050.htm
no DOI — not checkedUS Food and Drug Administration. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. March 8, 2018. Accessed April 10, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics
no DOI — not checkedUS Food and Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. May 12, 2016. Accessed April 10, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-advises-restricting-fluoroquinolone-antibiotic-use-certain
no DOI — not checkedThe Joint Commission. R3 Report Issue 23: antimicrobial stewardship in ambulatory health care. Accessed August 11, 2020. https://www.jointcommission.org/r3_report_23_antimicrobial_stewardship_in_ambulatory_health_care/
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1001/jamanetworkopen.2021.36662"><img src="https://citestamp.com/citestamped/10.1001/jamanetworkopen.2021.36662/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1001/jamanetworkopen.2021.36662)